Agilent Technologies
Investor profile
Corporate
Agilent Technologies has backed 2 European tech companies across 2 funding rounds between 2021 and 2024, joining rounds totalling €164M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2021–2024
4 yrs
Total round €
€164M
sum of rounds joined
Deals by year
distinct rounds / yearAgilent Technologies — deals by year — interactive chart.
Data table
| Agilent Technologies — deals by year | |
|---|---|
| 2021 | 1 |
| 2024 | 1 |
Top sectors
by dealsAgilent Technologies — top sectors — interactive chart.
Data table
| Agilent Technologies — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsAgilent Technologies — stages — interactive chart.
Data table
| Agilent Technologies — stages | |
|---|---|
| Other | 1 |
| Series C | 1 |
Countries
by dealsAgilent Technologies — countries — interactive chart.
Data table
| Agilent Technologies — countries | |
|---|---|
| France | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Alexandria Venture Investments1
- Arrowmark Partners1
- BlueYard Capital1
- Bpifrance Large Venture1
- Casdin Capital1
- Columbia Threadneedle Investments1
- Danaher Life Sciences1
- Farallon Capital1
- Fidelity Management and Research Company1
- Illumina Ventures1
- Kurma Partners1
- Longwall Ventures1
- LSP1
- M Ventures1
- Moore Strategic Ventures1
- Octopus Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| DNA Script | France | 1 | €142M |
| Biofidelity | UK | 1 | €22M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| DNA Script | Series C | €142M | 2021-10 |
| Biofidelity | Other | €22M | 2024-04 |